Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 36Leukemia 18Lymphoma, Non-Hodgkin 14Leukemia, Lymphocytic, Chronic, B-Cell 14Myelodysplastic Syndromes 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Congenital Abnormalities 8Lymphoma 7Multiple Myeloma 6Lymphoma, Follicular 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Hematologic Neoplasms 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 5Lymphoma, B-Cell, Marginal Zone 4Recurrence 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid 3Hodgkin Disease 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Colorectal Neoplasms 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2

Interventions

Melphalan 2venetoclax 1Lenalidomide 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Dexamethasone 1Calcium Dobesilate 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amyloidosis × Interleukin-2 × Other hematologic neoplasm × Clear all
NCT00952237 2018-04-25

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
13 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Amyloidosis, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡